Jay Olson
Stock Analyst at Oppenheimer
(4.12)
# 512
Out of 5,099 analysts
244
Total ratings
45.18%
Success rate
15.72%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TERN Terns Pharmaceuticals | Maintains: Outperform | $28 → $58 | $44.20 | +31.22% | 4 | Dec 9, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Outperform | $600 → $650 | $552.78 | +17.59% | 12 | Nov 20, 2025 | |
| IBIO iBio, Inc. | Initiates: Outperform | $5 | $2.77 | +80.51% | 1 | Oct 21, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Outperform | $84 → $90 | $78.77 | +14.26% | 4 | Oct 8, 2025 | |
| IMRX Immuneering | Maintains: Outperform | $21 → $30 | $5.99 | +400.83% | 3 | Sep 25, 2025 | |
| BCYC Bicycle Therapeutics | Maintains: Outperform | $48 → $44 | $7.34 | +499.46% | 4 | Aug 11, 2025 | |
| MNMD Mind Medicine (MindMed) | Reinstates: Outperform | $25 | $12.45 | +100.80% | 1 | Aug 4, 2025 | |
| ATAI Atai Beckley | Initiates: Outperform | $14 | $4.36 | +221.10% | 1 | Jul 29, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $97 → $115 | $253.35 | -54.61% | 2 | Jul 8, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Perform | $19 → $22 | $26.85 | -18.06% | 15 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $10.00 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $65 | $4.33 | +1,401.15% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $65 | $1.82 | +3,481.27% | 5 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $2.24 | +480.36% | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $78.47 | -4.42% | 9 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $90 | $57.44 | +56.69% | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $42 | $18.11 | +131.92% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | $41 → $33 | $41.30 | -20.10% | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $40 | $9.24 | +332.90% | 9 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $20 | $3.12 | +541.03% | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $6.27 | +378.47% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $270 → $255 | $174.96 | +45.75% | 25 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $81 → $82 | $94.40 | -13.14% | 14 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 → $10 | $27.43 | -63.54% | 4 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $138 | $36.60 | +277.05% | 8 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $8 | $4.02 | +99.00% | 1 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $380 | $316.00 | +20.25% | 23 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $216 → $219 | $152.90 | +43.23% | 15 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | $12 | $2.56 | +368.75% | 6 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 | $4.25 | +323.53% | 5 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 | $8.85 | +1,030.29% | 5 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $102 → $95 | $57.05 | +66.52% | 6 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $25 | $1.16 | +2,055.36% | 1 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 | $1.71 | +427.86% | 4 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,200 → $500 | $1.61 | +30,957.83% | 4 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | $25 → $21 | $14.37 | +46.11% | 9 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $4.24 | - | 2 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $84 | $18.87 | +345.15% | 1 | Mar 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $1.92 | - | 3 | Jul 11, 2017 |
Terns Pharmaceuticals
Dec 9, 2025
Maintains: Outperform
Price Target: $28 → $58
Current: $44.20
Upside: +31.22%
Madrigal Pharmaceuticals
Nov 20, 2025
Maintains: Outperform
Price Target: $600 → $650
Current: $552.78
Upside: +17.59%
iBio, Inc.
Oct 21, 2025
Initiates: Outperform
Price Target: $5
Current: $2.77
Upside: +80.51%
Ionis Pharmaceuticals
Oct 8, 2025
Maintains: Outperform
Price Target: $84 → $90
Current: $78.77
Upside: +14.26%
Immuneering
Sep 25, 2025
Maintains: Outperform
Price Target: $21 → $30
Current: $5.99
Upside: +400.83%
Bicycle Therapeutics
Aug 11, 2025
Maintains: Outperform
Price Target: $48 → $44
Current: $7.34
Upside: +499.46%
Mind Medicine (MindMed)
Aug 4, 2025
Reinstates: Outperform
Price Target: $25
Current: $12.45
Upside: +100.80%
Atai Beckley
Jul 29, 2025
Initiates: Outperform
Price Target: $14
Current: $4.36
Upside: +221.10%
Praxis Precision Medicines
Jul 8, 2025
Maintains: Outperform
Price Target: $97 → $115
Current: $253.35
Upside: -54.61%
ACADIA Pharmaceuticals
Jun 26, 2025
Maintains: Perform
Price Target: $19 → $22
Current: $26.85
Upside: -18.06%
May 27, 2025
Downgrades: Perform
Price Target: n/a
Current: $10.00
Upside: -
May 21, 2025
Initiates: Outperform
Price Target: $65
Current: $4.33
Upside: +1,401.15%
May 15, 2025
Maintains: Outperform
Price Target: $80 → $65
Current: $1.82
Upside: +3,481.27%
May 14, 2025
Maintains: Outperform
Price Target: $15 → $13
Current: $2.24
Upside: +480.36%
May 8, 2025
Maintains: Outperform
Price Target: $70 → $75
Current: $78.47
Upside: -4.42%
Mar 14, 2025
Upgrades: Outperform
Price Target: $90
Current: $57.44
Upside: +56.69%
Mar 3, 2025
Maintains: Outperform
Price Target: $50 → $42
Current: $18.11
Upside: +131.92%
Jan 24, 2025
Downgrades: Perform
Price Target: $41 → $33
Current: $41.30
Upside: -20.10%
Jan 13, 2025
Maintains: Outperform
Price Target: $60 → $40
Current: $9.24
Upside: +332.90%
Dec 11, 2024
Maintains: Outperform
Price Target: $80 → $20
Current: $3.12
Upside: +541.03%
Dec 6, 2024
Initiates: Outperform
Price Target: $30
Current: $6.27
Upside: +378.47%
Oct 31, 2024
Maintains: Outperform
Price Target: $270 → $255
Current: $174.96
Upside: +45.75%
Oct 30, 2024
Maintains: Outperform
Price Target: $81 → $82
Current: $94.40
Upside: -13.14%
Oct 17, 2024
Maintains: Outperform
Price Target: $9 → $10
Current: $27.43
Upside: -63.54%
Sep 25, 2024
Reiterates: Outperform
Price Target: $138
Current: $36.60
Upside: +277.05%
Aug 14, 2024
Assumes: Outperform
Price Target: $8
Current: $4.02
Upside: +99.00%
Aug 7, 2024
Maintains: Outperform
Price Target: $380
Current: $316.00
Upside: +20.25%
Aug 2, 2024
Maintains: Outperform
Price Target: $216 → $219
Current: $152.90
Upside: +43.23%
Jun 18, 2024
Maintains: Perform
Price Target: $12
Current: $2.56
Upside: +368.75%
May 15, 2024
Maintains: Outperform
Price Target: $18
Current: $4.25
Upside: +323.53%
May 15, 2024
Maintains: Outperform
Price Target: $100
Current: $8.85
Upside: +1,030.29%
May 10, 2024
Maintains: Outperform
Price Target: $102 → $95
Current: $57.05
Upside: +66.52%
Apr 12, 2024
Initiates: Outperform
Price Target: $25
Current: $1.16
Upside: +2,055.36%
Mar 27, 2024
Maintains: Outperform
Price Target: $9
Current: $1.71
Upside: +427.86%
Nov 30, 2023
Maintains: Outperform
Price Target: $1,200 → $500
Current: $1.61
Upside: +30,957.83%
Nov 22, 2023
Maintains: Perform
Price Target: $25 → $21
Current: $14.37
Upside: +46.11%
Oct 13, 2022
Downgrades: Perform
Price Target: n/a
Current: $4.24
Upside: -
Mar 20, 2018
Maintains: Outperform
Price Target: $70 → $84
Current: $18.87
Upside: +345.15%
Jul 11, 2017
Upgrades: Outperform
Price Target: n/a
Current: $1.92
Upside: -